| Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B P Marcellin, EJ Heathcote, M Buti, E Gane, RA de Man, Z Krastev, ... New England Journal of Medicine 359 (23), 2442-2455, 2008 | 1493 | 2008 |
| Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B EJ Heathcote, P Marcellin, M Buti, E Gane, A Robert, Z Krastev, ... Gastroenterology 140 (1), 132-143, 2011 | 652 | 2011 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 311 | 2017 |
| Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised … BE Sands, PM Irving, T Hoops, JL Izanec, LL Gao, C Gasink, ... The Lancet 399 (10342), 2200-2211, 2022 | 121 | 2022 |
| A randomized, double-blind, comparison of tenofovir DF (TDF) versus adefovir dipivoxil (ADV) for the treatment of HBeAg-negative chronic hepatitis B (CHB): study GS-US-174-0102 P Marcellin, M Buti, Z Krastev, G Germanidis, K Kaita, I Kotzev, ... Hepatology 46 (4 Suppl 1), 290A-291A, 2007 | 85 | 2007 |
| Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no … P Marcellin, EJ Gane, R Flisiak, HN Trinh, J Petersen, S Gurel, KD Kaita, ... Hepatology 60, 313A-314A, 2014 | 81 | 2014 |
| Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials DT Rubin, I Dotan, A DuVall, Y Bouhnik, G Radford-Smith, PDR Higgins, ... The lancet Gastroenterology & hepatology 7 (1), 17-27, 2022 | 70 | 2022 |
| Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B SG Lim, Z Krastev, TM Ng, G Mechkov, IA Kotzev, S Chan, E Mondou, ... Antimicrobial agents and chemotherapy 50 (5), 1642-1648, 2006 | 61 | 2006 |
| Historical epidemiology of hepatitis C virus in select countries—volume 4 A Maaroufi, A Vince, SM Himatt, R Mohamed, J Fung, O Opare‐Sem, ... Journal of viral hepatitis 24, 8-24, 2017 | 44 | 2017 |
| Melatonin protection against burn-induced hepatic injury by down-regulation and nuclear factor kappa B activation G Bekyarova, M Apostolova, I Kotzev International Journal of Immunopathology and Pharmacology 25 (3), 591-596, 2012 | 38 | 2012 |
| The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 HLY Chan, CJ Chen, O Omede, J Al Qamish, K Al Naamani, A Bane, ... Journal of viral hepatitis 24, 25-43, 2017 | 35 | 2017 |
| Strategies to manage hepatitis C virus infection disease burden—Volume 4 DS Chen, W Hamoudi, B Mustapha, J Layden, A Nersesov, T Reic, ... Journal of viral hepatitis 24, 44-63, 2017 | 34 | 2017 |
| Risk and protective factors for development of colorectal polyps and cancer I Kotzev, M Mirchev, B Manevska, I Ivanova, M Kaneva Hepato Gastroenterol 55, 381-387, 2008 | 34 | 2008 |
| Risk and protective factors for development of colorectal polyps and cancer I Kotzev, M Mirchev, B Manevska, I Ivanova, M Kaneva Hepato Gastroenterol 55, 381-387, 2008 | 34 | 2008 |
| Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and … P Marcellin, EJ Gane, N Tsai, R Flisiak, J Petersen, S Gurel, IA Kotzev, ... Hepatology 58, 649A, 2013 | 31 | 2013 |
| A double-blind, placebo-controlled trial of emtricitabine (FTC, Emtriva) administered once-daily for treatment of chronic hepatitis B virus (HBV) infection ML Shiffman, TM Ng, Z Krastev, IA Kotzev, G Mechkov, NNS Kung, ... Hepatology 40 (4), 172A-172A, 2004 | 28 | 2004 |
| Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infection DI Gerova, BT Galunska, II Ivanova, IA Kotzev, TG Tchervenkov, SP Balev, ... Scandinavian journal of clinical and laboratory investigation 74 (8), 665-672, 2014 | 27 | 2014 |
| Three Years of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg-Negative Patients with Chronic Hepatitis B (Study 102) P Marcellin, M Buti, Z Krastev, G Germanidis, K Kaita, I Kotzev, ... Hepatology 50 (Suppl 4), 532A-533A, 2009 | 25 | 2009 |
| Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study. Z Krastev, D Jelev, K Antonov, V Alagozian, I Kotzev Hepato-gastroenterology 46 (30), 3184-3188, 1999 | 20 | 1999 |
| DNA methylation in patients with colorectal cancer–correlation with some clinical and morphological features and with local tumour invasion MB Mirchev, P Kahl, N Friedrichs, IA Kotzev, R Buettner Folia Med (Plovdiv) 52 (2), 22-30, 2010 | 14 | 2010 |
Maria Butí FerretHospital VAlle HebronVerified email at comb.cat
